Volume 11, Issue 4 (Nov 2024)
Res Mol Med (RMM) 2024, 11(4): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mojarad-Jabali S, Molavipordanjani S. Clinical application of actinium-225 radiopharmaceuticals in targeted alpha therapy. Res Mol Med (RMM) 2024; 11 (4)
URL: http://rmm.mazums.ac.ir/article-1-553-en.html
URL: http://rmm.mazums.ac.ir/article-1-553-en.html
1- 1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran
2- 1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran ,sajjad.molavi@gmail.com
2- 1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran ,
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
